NEPHROCARE HEALTH SERV L (NEPHROPLUS)

NSE: ₹661.00
BSE: ₹661.30
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Dec 2025 Mar 2026
Revenue from Operations 160.66 164.33
YOY Revenue Growth % - -
Other Income 3.46 6.14
Total Income 164.13 170.47
Total Expenses + 155.17 159.48
Cost of Materials Consumed 40.15 41.01
Employee Benefit Expense 29.27 32.16
Other Expenses 68.38 69.09
Operating Profit 5.50 4.86
OPM % 3.4% 3%
Profit Before Tax + 8.96 10.99
Tax Expense 0.51 0.11
Tax % 5.6% 1%
Profit After Tax 8.45 10.89
EPS (Basic) 0.90 1.09

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026
Revenue from Operations 629.74
YOY Revenue Growth % -
Other Income 15.43
Total Income 645.18
Total Expenses + 648.95
Cost of Materials Consumed 160.73
Employee Benefit Expense 121.09
Other Expenses 259.76
Operating Profit -19.20
OPM % -3%
Profit Before Exceptional -3.77
Exceptional Items 0.00
Profit Before Tax + -3.77
Tax Expense 4.29
Tax % -
Profit After Tax -8.06
EPS (Basic) -0.89

Balance Sheet

Particulars Mar 2026
ASSETS
Non-Current Assets + 492.33
Property, Plant & Equipment 242.73
Capital Work in Progress 3.51
Non-Current Investments 164.68
Goodwill 0.00
Other Intangible Assets 2.05
Current Assets + 642.72
Inventories 18.13
Trade Receivables 217.66
Cash and Cash Equivalents 93.68
Current Investments 170.64
LIABILITIES & EQUITY
Total Equity 970.91
Equity Share Capital 20.07
Other Equity 950.84
Non-Current Liabilities 13.50
Current Liabilities 150.64
Total Liabilities 164.15

Cash Flow Statement

Particulars Mar 2026
Cash from Operating Activities 132.90
Cash from Investing Activities -298.75
Cash from Financing Activities 255.67
Net Increase/Decrease in Cash 89.82